Panacea Life Sciences Holdings Inc (PLSH): 20M shares was more than I thought, but...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Panacea Life Sciences Holdings Inc (PLSH)

Reply Private New

Keep Last Read

Next 10 Prev Next

FairviewInvestor

Send PM Follow Ignore

Followers	29
Posts	2446
Boards Moderated	0
Alias Born	11/22/2010

FairviewInvestor

Re: noshorthere post# 1443

Sunday, 07/11/2021 1:25:11 PM

Sunday, July 11, 2021 1:25:11 PM

20M shares was more than I thought, but it's still a good number.
I know of muliple groups of day traders who share due diligence and who trade in group at times.

50M O/S is their cut over.. anything over they really stay away from. big runners and parabolic runners cap out at around the O/S that EXDI will have post 1:28 split

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent PLSH News

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 01:00:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 03:28:08 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 07:24:23 PM
Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 12/08/2023 08:04:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 05:07:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2023 01:15:13 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2023 04:21:21 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2023 03:28:18 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 03:19:11 PM
Panacea Life Sciences Holdings, Inc. Chief Scientific Officer, Dr. James Baumgartner, is Featured on The Stock Day Podcast • InvestorsHub NewsWire • 07/18/2023 04:41:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 01:00:13 PM

More PLSH News

InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow